Patients with comorbid ALS-FTD typically face a faster disease progression and shorter survival—averaging 2–3 years —compared to those with only one of the conditions. 2. Common Pathological Root: TDP-43
Approximately 50% of ALS patients develop cognitive or behavioral impairment. Of these, about 10–15% meet the full diagnostic criteria for FTD. Amyotrophic Lateral Sclerosis and the Frontotem...
Frontotemporal Dementia and Amyotrophic Lateral Sclerosis - PMC Patients with comorbid ALS-FTD typically face a faster
The co-occurrence of motor and cognitive symptoms is far more common than previously thought: Amyotrophic Lateral Sclerosis and the Frontotem...